Scrip Regulatory Affairs
US FDA cites examples of its stricter medtech regulations vs EU
10 March 2011
Vibha Sharma
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- Australian Senate panel inquiry expresses shock at patient experiences with DePuy hip devices; calls for stricter regulations
- FDA report questions whether US rules can ensure quality of marketed medical devices
- EU medtech report calls for randomised clinical trials and centralised pre-market evaluation
- GAO finds gaps in the US FDA medical device recall procedures
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
